Skip to main content
METabolic EXplorer logo

METabolic EXplorer — Investor Relations & Filings

Ticker · METEX ISIN · FR0004177046 LEI · 969500VI1GSBPGD9B460 PA Manufacturing
Open in API
Filings indexed 524 across all filing types
Latest filing 2016-09-08 Declaration of Voting R…
Country FR France
Listing PA METEX

About METabolic EXplorer

https://www.metabolic-explorer.com/

METabolic EXplorer (METEX) is an industrial biotechnology company specializing in the development and industrialization of fermentation bioprocesses. The company produces functional ingredients and chemical intermediates from renewable, non-food raw materials, offering sustainable alternatives to petrochemical processes. Its portfolio is centered on three main product families: 1,3-propanediol (PDO) for cosmetics, liquid polymers, and textiles; butyric acid (BA) for animal nutrition and the flavors and fragrances market; and amino acids for animal feed. The company operates through its subsidiaries, METEX NØØVISTA, which manages the PDO and BA production, and METEX NØØVISTAGO, which focuses on amino acids and ingredients for animal nutrition.

Recent filings

Filing Released Lang Actions
Déclaration du nombre total de Droits de Vote et d'Actions composant le capital social
Declaration of Voting Results & Voting Rights Announcements Classification · 98% confidence The document is titled "Déclaration du nombre total de Droits de Vote et d'Actions composant le capital social" (Declaration of the total number of Voting Rights and Shares comprising the share capital) and is dated as of 31/08/2016. It explicitly lists the total number of shares and theoretical voting rights, as well as exercisable voting rights, referencing Article 223-16 of the AMF general regulation. This content directly relates to the official results of shareholder votes or the structure of voting rights, which aligns perfectly with the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA). It is not an AGM presentation, a full annual report, or a simple dividend notice.
2016-09-08 French
METabolic EXplorer confirme les meilleures performances nutritionnelles et économiques d'inoLa(TM) : Efficacité nutritionnelle supérieure de 35%
Earnings Release Classification · 85% confidence The document is a press release dated September 6, 2016, from METabolic EXplorer, detailing positive test results regarding the nutritional and economic performance of their product, inoLa™. It discusses scientific findings, comparisons to petrochemical alternatives (DL-Methionine), and market implications. This content is characteristic of an announcement intended to inform investors and the public about recent operational or product developments, often released outside of mandatory quarterly/annual filings. It is not a full Annual Report (10-K), an Interim Report (IR), a formal Audit Report (AR), or a transcript (CT). Since it is a specific announcement about product performance and market positioning, it fits best as a general corporate update. Given the options, it is most closely aligned with an Earnings Release (ER) if it were tied to a reporting period, but since it is a standalone scientific/commercial update, and not a formal regulatory filing announcement (RPA/RNS), it functions as a general corporate disclosure. However, looking closely at the definitions, it is a detailed update on business performance and outlook, which often overlaps with Management Discussion & Analysis (MDA) or a specific type of Investor Presentation (IP) if it were a slide deck. Since it is a narrative press release detailing performance metrics and future strategy implications, and it is not a formal regulatory filing like 10-K or IR, it is best classified as an Earnings Release (ER) if it contains key financial highlights, or a general Regulatory Filing (RNS) if it doesn't fit elsewhere. Given the detailed performance metrics (35% superior nutritional efficiency, impact on growth, fat production), it functions similarly to an Earnings Release highlighting key operational achievements, even if not strictly tied to a quarterly earnings report structure. If it were a formal regulatory filing, it would be RNS. Since it is a detailed performance update, ER or MDA are possibilities. ER is for initial announcements of periodical results (key highlights). This document details results of tests and their implications, which is a form of performance update. I will classify it as ER as it announces key performance metrics, which is the closest fit for a performance announcement that isn't a full financial report. FY 2016
2016-09-06 French
METabolic EXplorer confirms the superior nutritional and economic performance of inoLa(TM): 35% greater nutritional value
Regulatory Filings Classification · 95% confidence The document is a press release dated September 6, 2016, detailing positive trial results for a product called inoLa™, focusing on nutritional value, economic performance, and competitive advantage in the animal feed sector. It announces scientific findings and business updates, rather than presenting a formal regulatory filing (like 10-K, IR, or AR) or a transcript of a call. Since it is an announcement of business performance and product validation, it most closely aligns with an Earnings Release (ER) which typically covers key highlights, or potentially a Regulatory Filing (RNS) if it were less specific. Given the focus on performance metrics and results confirmation, ER is the best fit, as it functions as a periodic business update outside of the formal quarterly report structure. It is not a formal financial report itself, but an announcement of positive operational/product news.
2016-09-06 English
Mise à disposition du Rapport du Conseil d'Administration sur les résolutions soumises à l'Assemblée Générale du 15 septembre 2016
AGM Information Classification · 98% confidence The document is titled "METabolic EXplorer : Mise à disposition du Rapport du Conseil d'Administration sur les résolutions soumises à l'Assemblée Générale du 15 septembre 2016". It explicitly states that the 'Rapport du Conseil d'Administration sur les résolutions soumises à l'Assemblée Générale' (Report of the Board of Directors on the resolutions submitted to the General Meeting) has been made available to the public. The document itself is an announcement about the availability of this report, not the full report or the AGM presentation itself. The length (4345 chars) is relatively short, fitting the 'MENU VS MEAL' rule for an announcement. Since it announces the publication of required documentation related to an upcoming shareholder meeting (Assemblée Générale), it is best classified as a Report Publication Announcement (RPA), as it is announcing the release of a specific report related to the AGM process, rather than being the AGM material (AGM-R) or the proxy materials (PSI).
2016-08-25 French
Déclaration du nombre total de Droits de Vote et d'Actions composant le capital social
Declaration of Voting Results & Voting Rights Announcements Classification · 98% confidence The document is titled "Déclaration du nombre total de Droits de Vote et d'Actions composant le capital social" (Declaration of the total number of Voting Rights and Shares making up the share capital) and is dated as of 31/07/2016. It explicitly lists the total number of shares and theoretical voting rights, and calculates exercisable voting rights. This content directly relates to the official results of shareholder voting rights and the structure of the share capital, which aligns best with the 'Declaration of Voting Results & Voting Rights Announcements' category.
2016-08-24 French
METabolic EXplorer et Technip signent un accord afin d'évaluer une offre technologique combinée PDO/PTT
Regulatory Filings Classification · 95% confidence The document is a press release dated August 23, 2016, announcing a strategic agreement between METabolic EXplorer and Technip to evaluate a combined technology offering (PDO/PTT). This type of announcement, detailing a significant business development, partnership, or strategic move that is not a standard periodic financial report (like 10-K or IR), typically falls under general corporate news or regulatory filings. Since it describes a specific business transaction/partnership rather than a change in management (MANG), a financing event (CAP), or a legal matter (LTR), and it is not a standard financial report, it best fits the general 'Regulatory Filings' (RNS) category as a significant corporate announcement, or potentially 'M&A Activity' (TAR) if the evaluation leads to a transaction, but here it is purely an evaluation agreement. Given the options, RNS serves as the best catch-all for non-standard, material corporate news releases that aren't explicitly defined elsewhere. The length (6727 chars) is substantial enough that it is the primary document, not just an announcement of a document (RPA).
2016-08-23 French

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.